BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1899849)

  • 1. Responsiveness to phenobarbital in an adult with Crigler-Najjar disease associated with neurological involvement and skin hyperextensibility.
    Persico M; Romano M; Muraca M; Gentile S
    Hepatology; 1991 Feb; 13(2):213-5. PubMed ID: 1899849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and bile bilirubin pigments in the differential diagnosis of Crigler-Najjar disease.
    Rubaltelli FF; Novello A; Zancan L; Vilei MT; Muraca M
    Pediatrics; 1994 Oct; 94(4 Pt 1):553-6. PubMed ID: 7936872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual case of Crigler-Najjar disease in the adult. Classification into types I and II revisited.
    Duhamel G; Blanckaert N; Metreau JM; Préaux AM; Bouvry M; Fevery J; Berthelot P
    J Hepatol; 1985; 1(1):47-53. PubMed ID: 3932508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The differential diagnosis of Crigler-Najjar disease, types 1 and 2, by bile pigment analysis.
    Sinaasappel M; Jansen PL
    Gastroenterology; 1991 Mar; 100(3):783-9. PubMed ID: 1993500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unconjugated bilirubin and an increased proportion of bilirubin monoconjugates in the bile of patients with Gilbert's syndrome and Crigler-Najjar disease.
    Fevery J; Blanckaert N; Heirwegh KP; Préaux AM; Berthelot P
    J Clin Invest; 1977 Nov; 60(5):970-9. PubMed ID: 409736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fenofibrate treatment in two adults with Crigler-Najjar syndrome type II.
    Yilmaz S; Dursun M; Canoruç F; Kidir V; Beştaş R
    Turk J Gastroenterol; 2006 Mar; 17(1):62-5. PubMed ID: 16830281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis in Crigler-Najjar syndrome.
    Sherker AH; Heathcote J
    Am J Gastroenterol; 1987 Sep; 82(9):883-5. PubMed ID: 3115090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival in three brothers with severe type 2 Crigler-Najjar syndrome. Ultrastructural and metabolic studies.
    Gollan JL; Huang SN; Billing B; Sherlock S
    Gastroenterology; 1975 Jun; 68(6):1543-55. PubMed ID: 805737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful photo-and phenobarbital therapy during pregnancy in a woman with Crigler-Najjar syndrome type II.
    Holstein A; Plaschke A; Lohse P; Egberts EH
    Scand J Gastroenterol; 2005 Sep; 40(9):1124-6. PubMed ID: 16211719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orthotopic liver transplantation for type I Crigler-Najjar syndrome.
    Kaufman SS; Wood RP; Shaw BW; Markin RS; Rosenthal P; Gridelli B; Vanderhoof JA
    Hepatology; 1986; 6(6):1259-62. PubMed ID: 3098664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orlistat treatment of unconjugated hyperbilirubinemia in Crigler-Najjar disease: a randomized controlled trial.
    Hafkamp AM; Nelisse-Haak R; Sinaasappel M; Oude Elferink RP; Verkade HJ
    Pediatr Res; 2007 Dec; 62(6):725-30. PubMed ID: 17957158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile bilirubin pigment analysis in disorders of bilirubin metabolism in early infancy.
    Lee WS; McKiernan PJ; Beath SV; Preece MA; Baty D; Kelly DA; Burchell B; Clarke DJ
    Arch Dis Child; 2001 Jul; 85(1):38-42. PubMed ID: 11420196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phenobarbital on serum and biliary parameters in a patient with Crigler-Najjar syndrome, type II and acquired cholestasis.
    Trotman BW; Shaw L; Roy-Chowdhury J; Malet PF; Rosato EF
    Dig Dis Sci; 1983 Aug; 28(8):753-62. PubMed ID: 6872808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal excretion of unconjugated bilirubin in man and rats with inherited unconjugated hyperbilirubinemia.
    Kotal P; Van der Veere CN; Sinaasappel M; Elferink RO; Vítek L; Brodanová M; Jansen PL; Fevery J
    Pediatr Res; 1997 Aug; 42(2):195-200. PubMed ID: 9262222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of three methods evaluating the saturation of serum bilirubin transporters in children with type I Crigler Najjar disease].
    Francoual J; Myara A; Trivin F; Leluc R; Odièvre M
    Arch Fr Pediatr; 1990 Dec; 47(10):721-3. PubMed ID: 2082845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilirubin secretion and conjujation in the Crigler-Najjar syndrome type II.
    Gordon ER; Shaffer EA; Sass-Kortsak A
    Gastroenterology; 1976 May; 70(5 PT.1):761-5. PubMed ID: 1261771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delayed response to phenobarbital treatment of a Crigler-Najjar type II patient with partially inactivating missense mutations in the bilirubin UDP-glucuronosyltransferase gene.
    Ciotti M; Werlin SL; Owens IS
    J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):210-3. PubMed ID: 9932859
    [No Abstract]   [Full Text] [Related]  

  • 18. Threshold concentration of unbound bilirubin to induce neurological deficits in a patient with type I Crigler-Najjar syndrome.
    Ihara H; Hashizume N; Shimizu N; Aoki T
    Ann Clin Biochem; 1999 May; 36 ( Pt 3)():347-52. PubMed ID: 10376077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anesthetic and postoperative care of a patient with Crigler-Najjar syndrome type II].
    Hamada T; Miyamoto M; Oda S; Taniguchi K; Honda N
    Masui; 1996 Mar; 45(3):345-7. PubMed ID: 8721137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crigler-Najjar disease in pregnancy.
    Smith JF; Baker JM
    Obstet Gynecol; 1994 Oct; 84(4 Pt 2):670-2. PubMed ID: 9205443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.